https://www.selleckchem.com/pr....oducts/paeoniflorin.
05). We observed a marginally lower relative abundance of bacteria belonging to Clostridium group IV in PD patients who experienced a medium or large improvement in motor impairment in response to Levodopa compared to those with a small response [β = -0.64 (SE 0.18), p-trend 0.00015 p-FDR 0.019]. Conclusions In this study, Levodopa was not associated with changes in microbiota composition in this longitudinal analysis. The association between abundance of Clostridium group IV and short-term motor symptom response to Levodopa is pre
Curtir
Comentario
Compartilhar
